#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	528	16	ANT_2____Ia	750	172	98.29	ANT_2____Ia.l6.c30.ctg.1	216	2.4	0	.	p	.	0	F31_V32insG	INS	91	91	T	132	132	T	3	T	3	.	ANT(2'')-Ia;Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	426	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1084	21.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	297	299	ACG	26;27;28	A;C;G	26;27;28	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	266	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c30.ctg.1	122	26.5	0	.	n	.	0	G906T	SNP	906	906	G	17	17	T	13	T	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	266	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c30.ctg.1	122	26.5	0	.	n	.	0	G908A	SNP	908	908	G	19	19	A	14	A	14	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	266	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c30.ctg.1	122	26.5	0	.	n	.	0	A918T	SNP	918	918	A	29	29	T	20	T	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	266	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c30.ctg.1	122	26.5	0	.	n	.	0	A943G	SNP	943	943	A	54	54	G	58	G	58	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	266	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c30.ctg.1	122	26.5	0	.	n	.	0	G991T	SNP	991	991	G	102	102	T	28	T	28	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	659	1326	Escherichia_coli_EF_Tu	1185	1183	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1392	47.0	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1178	1180	AGC	29;29;29	A,G;G;C	21,8;29;28	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	659	1326	Escherichia_coli_EF_Tu	1185	1183	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1392	47.0	0	HET	.	.	.	T135C	.	135	135	T	133	133	T	43	T,C	24,17	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	659	1326	Escherichia_coli_EF_Tu	1185	1183	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1392	47.0	0	HET	.	.	.	C216T	.	216	216	C	214	214	C	47	C,T	35,12	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	514	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1717	16.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1528	1530	AAA	11;10;10	A;A;A	11;10;10	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	662	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c4.ctg.1	1706	20.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1198	1200	GAA	34;34;33	G;A;A	34;34;33	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	132	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	754	9.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	644	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1450	23.9	0	.	p	.	0	H2R	NONSYN	4	6	CAT	198	200	CGT	28;28;28	C;G;T	28;28;28	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	644	PmrB_1	1092	1092	99.18	PmrB_1.l6.c4.ctg.1	1450	23.9	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1041	1043	GGC	26;25;25	G;G;C	26;25;25	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1957	20.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	189	191	AGC	13;13;14	A;G;C	13;13;14	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1957	20.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	591	593	CTA	25;25;24	C;T;A	25;25;24	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1957	20.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1110	1112	CAA	22;21;21	C;A;A	22;21;21	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1957	20.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1209	1211	GGT	31;31;31	G;G;T	31;31;31	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	752	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1957	20.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1779	1781	GTT	5;4;4	G;T;T	5;4;4	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	300	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1394	11.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	542	544	GAA	10;10;10	G;A;A	10;10;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	300	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1394	11.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	722	724	ACC	5;5;5	A;C;C	5;5;5	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	300	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1394	11.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	842	844	ACT	5;4;4	A;C;T	5;4;4	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	300	PmrE	1167	1167	96.92	PmrE.l15.c4.ctg.1	1394	11.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1232	1234	ATC	10;10;10	A;T;C	10;10;10	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	531	418	PmrF	969	969	98.97	PmrF.l15.c4.ctg.1	1388	16.2	0	.	p	.	0	G38fs	FSHIFT	112	112	G	296	296	G	12	G	12	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	528	46	TEM_1+	858	268	98.51	TEM_1+.l6.c30.ctg.1	330	3.3	0	.	p	.	0	K4Q	NONSYN	10	12	AAA	72	74	CAA	2;2;2	C;A;A	2;2;2	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	528	46	TEM_1+	858	268	98.51	TEM_1+.l6.c30.ctg.1	330	3.3	0	.	p	.	0	V82I	NONSYN	244	246	GTT	306	308	ATT	1;1;1	A;T;T	1;1;1	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
aadA23.3002620.AJ809407.118_898.280	aadA23.3002620.AJ809407.118_898.280	1	0	0	58	aad-	780	167	99.4	aad-.l6.c30.ctg.1	167	2.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aadA23;aadA23 is an integron-encoded aminoglycoside nucleotidyltransferase gene in S. enterica
aadA23.3002620.AJ809407.118_898.280	aadA23.3002620.AJ809407.118_898.280	1	0	0	58	aad-	780	204	100.0	aad-.l6.c30.ctg.3	204	3.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aadA23;aadA23 is an integron-encoded aminoglycoside nucleotidyltransferase gene in S. enterica
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1376	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3476	21.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	444	446	ATC	21;22;22	A;T;C	21;22;22	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1376	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3476	21.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2157	2159	AAG	19;19;23	A;A;G	18;19;23	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	542	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1519	19.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	252	254	GTC	10;9;10	G;T;C	10;9;10	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	542	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1519	19.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	993	995	TGC	32;33;31	T;G;C	32;33;31	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	192	192	T	7	T	7	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	498	500	GAC	25;25;25	G;A;C	24;25;24	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	774	776	TTA	9;9;11	T;T;A	9;9;10	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1851	1853	AAT	34;34;33	A;A;T	34;34;33	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1965	1967	AGT	22;24;24	A;G;T	22;24;24	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2364	2366	GTG	22;22;22	G;T;G	22;22;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1520	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3333	24.1	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2919	2921	AAG	19;21;23	A;A,G;G	19;20,1;23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	350	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1021	18.5	1	SNP	p	R45C	0	.	.	133	135	CGC	324	326	CGC	22;21;21	C;G;C	22;21;21	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	292	acrS	663	663	98.79	acrS.l6.c4.ctg.1	1024	15.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	268	270	TTC	11;11;11	T;T;C	11;11;11	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	292	acrS	663	663	98.79	acrS.l6.c4.ctg.1	1024	15.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	532	534	GGG	20;20;20	G;G;G	20;20;20	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	394	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1153	18.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	603	605	CTT	31;32;31	C;T;T	31;32;31	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1284	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3057	22.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2080	2082	GCA	29;29;30	G;C;A	28;29;30	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1284	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3057	22.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2341	2343	ACC	14;14;14	A;C;C	14;14;13	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1284	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3057	22.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2650	2652	GCC	24;23;24	G;C;C	24;22;24	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	108	98.15	arnA_1.l15.c4.ctg.1	234	6.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	4	6	GCT	4;4;5	G;C;T,C	4;4;4,1	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	124	126	GAG	4;4;4	G;A;G	4;4;4	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	160	162	TGC	6;6;6	T;G;C	6;6;6	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	343	345	GTT	15;16;16	G;T;T	15;16;16	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	493	495	CAC	13;13;13	C;A;C	13;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	778	780	ATG	28;27;27	A;T;G	27;27;27	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	515	704	arnA_1	1983	1878	98.3	arnA_1.l15.c4.ctg.2	2061	17.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1774	1776	CGC	10;10;10	C;G;C	10;10;10	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	344	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1045	16.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	862	864	ACC	8;8;8	A;C;C	8;8;8	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	344	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1045	16.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	874	876	TCG	11;11;11	T;C;G	11;11;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	200	baeR	723	683	97.8	baeR.l15.c17.ctg.1	874	11.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	514	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1432	18.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1143	1145	AAA	14;14;15	A;A;A	13;14;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	514	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1432	18.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1155	1157	GAG	16;15;14	G;A;G	15;12;10	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	514	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1432	18.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1161	1163	CAC	14;13;12	C;A;C	13;12;12	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	514	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1432	18.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1215	1217	GAG	15;15;15	G;A;G	15;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	750	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1565	24.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	404	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1046	20.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	358	cysB	975	975	99.38	cysB.l6.c30.ctg.1	1320	14.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	1	0	0	16	dfhr3b	480	97	100.0	dfhr3b.l15.c4.ctg.1	97	2.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: AY162283.2 Citrobacter freundii transposon class I integron In38 IntI1 integron integrase (intI1) gene, partial cds, aminoglycoside (6') N-acetyltransferase AAC(6')-II (aacA4), beta-lactamase OXA-4 (bla(OXA-4)), quaternary ammonium compound resistance protein (qacEdelta1), dihydropteroate synthase (sul1), Orf513 (orf513), dihydrofolate reductase type IIIb (dfrA3b), and Orf105 (orf105) genes, complete cds, qacEdelta1 pseudogene, complete sequence, and dihydropteroate synthase (sul1) gene, partial cds
dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	dfhr3b.manually_added_AY162283_AAN85115.1_5616_6095	1	0	0	16	dfhr3b	480	95	100.0	dfhr3b.l15.c4.ctg.2	112	2.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: AY162283.2 Citrobacter freundii transposon class I integron In38 IntI1 integron integrase (intI1) gene, partial cds, aminoglycoside (6') N-acetyltransferase AAC(6')-II (aacA4), beta-lactamase OXA-4 (bla(OXA-4)), quaternary ammonium compound resistance protein (qacEdelta1), dihydropteroate synthase (sul1), Orf513 (orf513), dihydrofolate reductase type IIIb (dfrA3b), and Orf105 (orf105) genes, complete cds, qacEdelta1 pseudogene, complete sequence, and dihydropteroate synthase (sul1) gene, partial cds
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	468	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1319	18.5	0	.	p	.	0	W42C	NONSYN	124	126	TGG	182	184	TGT	9;10;9	T;G;T	9;10;9	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	468	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1319	18.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	713	715	GTC	23;24;24	G;T;C	23;23;23	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	762	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	1944	21.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	610	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1393	22.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	808	810	AGC	16;17;17	A;G;C	16;17;17	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	16	emrE_1	333	89	96.63	emrE_1.l15.c4.ctg.2	89	4.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	418	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1463	15.3	0	.	p	.	0	K176R	NONSYN	526	528	AAG	729	731	AGG	13;13;13	A;G;G	13;12;13	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	418	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1463	15.3	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1119	1121	GAC	11;10;10	G;A;C	11;10;10	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	318	emrR	531	531	100.0	emrR.l15.c4.ctg.1	891	19.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	604	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	2003	16.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	226	evgA	615	615	99.19	evgA.l6.c4.ctg.1	847	13.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	253	255	CTG	16;15;15	C;T;G	16;15;15	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	201	203	AAA	14;14;15	A;A;A	14;14;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	936	938	CAT	15;15;15	C;A;T	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	990	992	CAT	7;7;7	C;A;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1008	1010	AGA	16;16;17	A;G;A	16;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1023	1025	AAT	19;19;19	A;A;T	19;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1170	1172	TCC	8;8;10	T;C;C	8;8;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1335	1337	ATT	13;12;12	A;T;T	13;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1356	1358	GAT	13;14;14	G;A;T	13;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1470	1472	GTT	13;13;12	G;T;T	13;13;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	2498	97.84	evgS.l15.c17.ctg.1	2671	19.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1755	1757	CAC	20;20;19	C;A;C	20;20;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	129	131	ATA	6;6;6	A;T;A	5;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	141	143	GTA	5;6;6	G;T;A	5;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	294	296	ACG	10;10;8	A;C;G	10;10;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	357	359	GAA	11;13;13	G;A;A	10;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	396	398	GCT	12;12;14	G;C;T	12;12;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	414	416	GAT	14;14;14	G;A;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	577	97.23	evgS.l15.c17.ctg.2	594	13.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	501	503	TCA	17;16;17	T;C;A	17;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	305	98.03	evgS.l15.c17.ctg.3	305	13.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	129	131	GTT	9;9;5	G;T;T	9;9;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	305	98.03	evgS.l15.c17.ctg.3	305	13.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	285	287	GAT	6;6;6	G;A;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1238	evgS	3594	162	95.06	evgS.l15.c17.ctg.4	162	13.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	145	147	AAT	6;6;6	A;A;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	460	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1177	21.0	1	SNP	p	P64S	0	.	.	190	192	CCA	331	333	CCA	31;30;29	C;C;A	31;30;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	460	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1177	21.0	1	SNP	p	P64A	0	.	.	190	192	CCA	331	333	CCA	31;30;29	C;C;A	31;30;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	460	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1177	21.0	1	SNP	p	P64R	0	.	.	190	192	CCA	331	333	CCA	31;30;29	C;C;A	31;30;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	460	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1177	21.0	1	SNP	p	P64H	0	.	.	190	192	CCA	331	333	CCA	31;30;29	C;C;A	31;30;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	460	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1177	21.0	1	SNP	p	P64L	0	.	.	190	192	CCA	331	333	CCA	31;30;29	C;C;A	31;30;29	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	260	gadE	528	528	100.0	gadE.l15.c17.ctg.1	905	15.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	138	97.1	gadW.l15.c4.ctg.1	138	11.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	68	gadW	729	154	94.81	gadW.l15.c4.ctg.2	155	7.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	25	27	AAT	3;3;4	A;A;T	3;3;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	294	gadX	825	344	97.97	gadX.l15.c4.ctg.3	439	10.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	269	271	GGA	13;13;13	G;G;A	13;13;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	294	gadX	825	344	97.97	gadX.l15.c4.ctg.3	439	10.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	275	277	CCG	15;14;14	C;C;G	15;14;14	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	294	gadX	825	72	98.61	gadX.l15.c4.ctg.5	154	11.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	294	gadX	825	410	97.8	gadX.l15.c4.ctg.6	421	15.2	0	.	p	.	0	F53L	NONSYN	157	159	TTC	168	170	TTA	15;15;14	T;T;A	15;15;14	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	513	294	gadX	825	410	97.8	gadX.l15.c4.ctg.6	421	15.2	0	.	p	.	0	V79I	NONSYN	235	237	GTT	246	248	ATT	13;13;11	A;T;T	13;13;11	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2194	2196	GAA	21;21;23	G;A;A	21;21;23	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	S83I	0	.	.	247	249	TCG	409	411	TCG	26;26;24	T;C;G	23;25;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	S83L	0	.	.	247	249	TCG	409	411	TCG	26;26;24	T;C;G	23;25;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	S83W	0	.	.	247	249	TCG	409	411	TCG	26;26;24	T;C;G	23;25;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	D87H	0	.	.	259	261	GAC	421	423	GAC	24;24;24	G;A;C	23;21;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	D87G	0	.	.	259	261	GAC	421	423	GAC	24;24;24	G;A;C	23;21;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	D87V	0	.	.	259	261	GAC	421	423	GAC	24;24;24	G;A;C	23;21;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	D87N	0	.	.	259	261	GAC	421	423	GAC	24;24;24	G;A;C	23;21;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1118	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	2965	20.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	421	423	GAC	24;24;24	G;A;C	23;21;24	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136L	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136C	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136E	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136G	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136I	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136H	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2755	23.3	1	SNP	p	R136S	0	.	.	406	408	CGC	590	592	CGC	16;16;17	C;G;C	16;16;17	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	254	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	956	14.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	376	378	CCG	20;18;19	C;C;G	20;18;19	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	254	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	956	14.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	529	531	GCC	12;12;12	G;C;C	12;11;12	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	508	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1273	21.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	166	168	TCA	20;20;20	T;C;A	20;20;20	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	180	marA	384	384	99.74	marA.l15.c4.ctg.1	709	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	474	476	AGC	7;7;7	A;G;C	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	576	578	CAT	3;3;3	C;A;T	3;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	V45E	0	.	.	133	135	GTG	300	302	GTG	18;18;18	G;T;G	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	I49S	0	.	.	145	147	ATC	312	314	ATC	16;15;15	A;T;C	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	A70T	0	.	.	208	210	GCA	375	377	GCA	19;19;19	G;C;A	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	R73C	0	.	.	217	219	CGT	384	386	CGT	17;16;15	C;G;T	17;16;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	R73S	0	.	.	217	219	CGT	384	386	CGT	17;16;15	C;G;T	17;16;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	R77C	0	.	.	229	231	CGC	396	398	CGC	13;12;12	C;G;C	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	R77L	0	.	.	229	231	CGC	396	398	CGC	13;12;12	C;G;C	13;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	L78M	0	.	.	232	234	CTG	399	401	CTG	11;10;8	C;T;G	11;10;8	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	R94H	0	.	.	280	282	CGC	447	449	CGC	6;7;7	C;G;C	6;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	R94S	0	.	.	280	282	CGC	447	449	CGC	6;7;7	C;G;C	6;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	104	marR	435	435	97.7	marR.l6.c4.ctg.1	636	8.5	1	SNP	p	V96E	0	.	.	286	288	GTA	453	455	GTA	7;7;7	G;T;A	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	S7F	NONSYN	19	21	TCC	20	22	TTC	4;4;4	T;T;C	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	107	109	ATC	11;9;8	A;T;C	11;9;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	125	127	GCC	2;2;2	G;C;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	128	130	GTG	2;2;2	G;T;G	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	E52D	NONSYN	154	156	GAG	155	157	GAT	5;5;5	G;A;T	5;3;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	N59T	NONSYN	175	177	AAC	176	178	ACC	5;5;5	A;C;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	I68L	NONSYN	202	204	ATA	203	205	TTA	7;7;7	T;T;A	7;6;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	364	mdfA	1233	1233	96.67	mdfA.l15.c4.ctg.2	1228	15.0	0	.	p	.	0	G88fs	FSHIFT	262	262	G	263	263	G	10	G	9	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	366	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1420	13.1	0	.	p	.	0	V12trunc	TRUNC	34	34	G	36	36	G	12	G	11	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	366	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1420	13.1	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	93	95	CAG	14;14;12	C;A;G	13;13;12	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	366	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1420	13.1	0	.	p	.	0	T83I	NONSYN	247	249	ACC	243	245	ATC	5;5;5	A;T;C	5;5;5	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	366	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1420	13.1	0	.	p	.	0	I99M	NONSYN	295	297	ATA	291	293	ATG	7;9;9	A;T;G	7;9;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	366	mdtA	1248	1248	97.44	mdtA.l6.c4.ctg.1	1420	13.1	0	.	p	.	0	A130T	NONSYN	388	390	GCC	384	386	ACC	7;7;6	A;C;C	7;7;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1905	1907	ACC	20;21;21	A;C;C	19;21;21	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2298	2300	CAA	19;21;22	C;A;A,G	19;21;20,1	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2466	2468	ATT	13;12;12	A;T;T	13;12;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2550	2552	GTT	15;15;15	G;T;T	15;15;15	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2658	2660	GAG	12;12;12	G;A;G	12;12;12	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2886	2888	ATG	19;18;17	A;T;G	19;18;17	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1292	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3364	20.5	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3021	3023	GAT	26;27;28	G;A;T	26;26;28	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	958	mdtC	3078	2947	98.68	mdtC.l15.c17.ctg.1	2956	16.7	0	.	p	.	0	I46M	NONSYN	136	138	ATC	145	147	ATG	9;10;10	A;T;G	9;10;10	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	958	mdtC	3078	2947	98.68	mdtC.l15.c17.ctg.1	2956	16.7	0	.	p	.	0	V208I	NONSYN	622	624	GTC	631	633	ATC	14;14;13	A;T;C	14;14;13	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	958	mdtC	3078	2947	98.68	mdtC.l15.c17.ctg.1	2956	16.7	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2947	2949	CAC	3;3;3	C;A;C	3;3;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	476	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1739	14.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	123	125	GAA	8;7;7	G;A;A	8;7;7	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	476	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1739	14.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	792	794	GCG	27;26;26	G;C;G	27;26;26	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	476	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1739	14.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1134	1136	ATC	15;15;16	A;T;C	15;15;16	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	476	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1739	14.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1437	1439	TTT	21;20;21	T;T;T	21;19;21	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	632	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1533	22.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1616	mdtF	3114	3114	98.52	mdtF.l15.c17.ctg.1	3455	25.2	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1058	1060	ACC	23;23;23	A;C;C	22;22;23	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1616	mdtF	3114	3114	98.52	mdtF.l15.c17.ctg.1	3455	25.2	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2300	2302	GAC	33;36;34	G;A;C	33;36;34	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	512	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1421	15.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	608	610	ATC	22;22;24	A;T;C	22;22;24	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	512	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	330	12.0	0	.	p	.	0	E5G	NONSYN	13	15	GAA	152	154	GGA	9;9;9	G;G;A	9;9;9	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	448	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1479	16.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	550	552	TGT	17;17;17	T;G;T	17;17;17	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	448	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1479	16.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1120	1122	TTG	11;11;11	T;T;G	11;11;11	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	448	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1479	16.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1330	1332	ACG	9;8;8	A;C;G	9;8;8	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	578	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1538	20.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	738	740	TCC	16;16;18	T;C;C	15;15;18	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	430	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1429	16.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	544	546	ATT	19;18;18	A;T;T	19;18;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	V11M	NONSYN	31	33	GTG	115	117	ATG	12;12;12	A;T;G	11;12;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	T33I	NONSYN	97	99	ACC	181	183	ATC	18;18;18	A;T;C	18;18;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	C116R	NONSYN	346	348	TGC	430	432	CGC	33;30;30	C;G;C	33;30;30	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	N238S	NONSYN	712	714	AAC	796	798	AGC	22;23;23	A;G;C	22;23;23	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	M305V	NONSYN	913	915	ATG	997	999	GTG	21;20;20	G;T;G	21;20;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1060	1062	AAC	8;8;8	A;A;C	7;6;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1105	1107	GTC	28;28;28	G;T;C	27;27;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1135	1137	ATA	26;25;25	A;T;A	26;25;25	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1243	1245	TCT	21;22;22	T;C;T	21;22;22	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1630	1632	GCG	24;24;24	G;C;G	24;23;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	890	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2348	20.2	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1843	1845	ATC	21;20;20	A;T;C	21;20;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	255	255	T	26	T	26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	438	440	GCG	20;20;18	G;C;G	20;20;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	612	614	ACC	11;10;10	A;C;C	11;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	684	686	CGC	31;30;30	C;G;C	31;29;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	801	803	GCT	19;19;21	G;C;T	19;19;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	885	887	AAA	12;12;12	A;A;A	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	903	905	CGA	12;11;11	C;G;A	12;11;11	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1068	1070	GCC	19;19;19	G;C;C	19;19;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1080	1082	GAT	16;17;17	G;A;T	16;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	648	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1706	19.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1497	1499	GCT	11;11;12	G;C;T	11;11;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1350	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3833	19.0	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1497	1499	AAG	18;18;17	A;A;G	18;18;17	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1350	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	3833	19.0	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2574	2576	CTG	19;20;20	C;T;G	19;20;20	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	90	mgrB	144	144	100.0	mgrB.l6.c4.ctg.1	535	9.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	752	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2073	19.5	0	.	p	.	0	S278N	NONSYN	832	834	AGC	966	968	AAC	23;22;22	A;A;C	23;22;22	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	752	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2073	19.5	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1512	1514	ATA	25;24;22	A;T;A	25;24;22	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	684	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1651	22.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1288	1290	GAT	28;30;31	G;A;T	28;30;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	684	murA_12	1260	1260	98.57	murA_12.l15.c30.ctg.1	1651	22.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1291	1293	CTG	32;32;32	C;T;G	32;32;32	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	0	.	p	.	0	R27C	NONSYN	79	81	CGT	112	114	TGT	7;7;8	T;G;T	7;7;8	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	0	.	p	.	0	I117T	NONSYN	349	351	ATC	382	384	ACC	20;19;16	A;C;C	20;19;16	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	0	.	p	.	0	G187D	NONSYN	559	561	GGC	592	594	GAC	16;18;17	G;A;C	16;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	1	SNP	p	R15C	0	.	.	43	45	CGC	76	78	CGC	18;18;18	C;G;C	18;18;18	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	1	SNP	p	S33R	0	.	.	97	99	AGC	130	132	AGC	9;8;8	A;G;C	9;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	1	SNP	p	G131D	0	.	.	391	393	GGC	424	426	GGC	21;22;22	G;G;C	20;22;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	1	SNP	p	R203C	0	.	.	607	609	CGT	640	642	CGT	19;20;20	C;G;T	19;20;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	260	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	923	14.4	1	SNP	p	R203L	0	.	.	607	609	CGT	640	642	CGT	19;20;20	C;G;T	19;20;20	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1435	21.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1110	1112	GAG	25;24;25	G;A;G	25;24;25	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1435	21.1	1	SNP	p	G141E	0	.	.	421	423	GGT	597	599	GGT	29;28;28	G;G;T	29;28;28	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1435	21.1	1	SNP	p	G141D	0	.	.	421	423	GGT	597	599	GGT	29;28;28	G;G;T	29;28;28	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1435	21.1	1	SNP	p	R154A	0	.	.	460	462	CGT	636	638	CGT	30;30;29	C;G;T	30;30;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	564	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1435	21.1	1	SNP	p	R154D	0	.	.	460	462	CGT	636	638	CGT	30;30;29	C;G;T	30;30;29	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1202	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2618	24.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1822	1824	TCG	31;32;33	T;C;G	31;31;33	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1202	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2618	24.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2437	2439	AAC	7;7;7	A;A;C	7;7;7	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1202	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2618	24.7	1	SNP	p	A85T	0	.	.	253	255	GCG	451	453	GCG	20;20;21	G;C;G	20;19;21	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1202	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2618	24.7	1	SNP	p	D111H	0	.	.	331	333	GAT	529	531	GAT	14;14;13	G;A;T	14;14;13	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1202	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2618	24.7	1	SNP	p	S129P	0	.	.	385	387	TCC	583	585	TCC	30;31;31	T;C;C	30;31;31	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	722	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2123	17.7	0	.	p	.	0	D476A	NONSYN	1426	1428	GAT	1447	1449	GCT	27;26;26	G;C,A;T	27;24,2;26	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	736	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1772	22.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1259	1261	GAT	28;30;31	G;A;T	28;28;31	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	V146F	0	.	.	436	438	GTT	620	622	GTT	17;18;18	G,A;T;T	16,1;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1721	1723	CAG	25;23;24	C;A;G	25;23;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1721	1723	CAG	25;23;24	C;A;G	25;23;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1760	1762	CAC	22;23;23	C;A;C	22;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1769	1771	CGT	24;22;22	C;G;T	24;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1769	1771	CGT	24;22;22	C;G;T	24;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1775	1777	TCC	20;20;20	T;C;C	20;20;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1781	1783	CTC	18;17;17	C;T;C	18;17;17	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1871	1873	ACC	23;22;22	A;C;C	23;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1874	1876	CCT	22;22;22	C;C;T	22;22;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2210	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4403	27.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2243	2245	CGT	34;34;34	C;G;T	34;34;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	.	n	.	0	A226G	SNP	226	226	A	229	229	G	201	G	199	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	.	n	.	0	C719T	SNP	719	719	C	722	722	T	162	T,C	88,74	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	A794T	0	.	.	794	794	A	797	797	A	188	A,C	187,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	A794G	0	.	.	794	794	A	797	797	A	188	A,C	187,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	G926T	0	.	.	926	926	G	929	929	G	208	G	207	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	G926A	0	.	.	926	926	G	929	929	G	208	G	207	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	G926C	0	.	.	926	926	G	929	929	G	208	G	207	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	A1519T	0	.	.	1519	1519	A	1522	1522	A	118	A	116	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	A1519C	0	.	.	1519	1519	A	1522	1522	A	118	A	116	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	1	SNP	n	A1519G	0	.	.	1519	1519	A	1522	1522	A	118	A	116	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	C194T	.	194	194	C	197	197	C	194	C,T	153,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	G1002A	.	1002	1002	G	1005	1005	G	220	G,A	143,77	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	G1006C	.	1006	1006	G	1009	1009	G	210	G,C	136,73	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	A79G	.	79	79	A	82	82	A	154	A,G	111,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	T273A	.	273	273	T	276	276	T	175	T,A	124,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	A250T	.	250	250	A	253	253	A	189	A,T	141,47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	T1010C	.	1010	1010	T	1013	1013	T	209	T,C	137,70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	C1038T	.	1038	1038	C	1041	1041	C	182	C,T	125,56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	C183T	.	183	183	C	186	186	C	190	C,T	126,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	G474A	.	474	474	G	477	477	G	175	G,A	126,47	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	T90C,A	.	90	90	T	93	93	T	155	T,C,A	109,43,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6074	rrsB+	1542	1542	99.87	rrsB+.l15.c30.ctg.2	1558	189.6	0	HET	.	.	.	A253T	.	253	253	A	256	256	A	188	A,T	139,48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	284	soxR	465	465	100.0	soxR.l15.c17.ctg.1	626	22.5	1	SNP	p	R20H	0	.	.	58	60	CGC	165	167	CGC	31;31;30	C;G;C	29;31;29	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	284	soxR	465	465	100.0	soxR.l15.c17.ctg.1	626	22.5	1	SNP	p	G121D	0	.	.	361	363	GGT	468	470	GGT	18;18;19	G;G;T	18;18;19	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	216	soxS_1	324	324	99.69	soxS_1.l15.c17.ctg.1	720	16.0	1	SNP	p	A12S	0	.	.	34	36	GCA	233	235	GCA	23;23;25	G;C;A	23;23;25	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul1.3000410.JF969163.1053_1893.340	sul1.3000410.JF969163.1053_1893.340	1	0	27	110	sul1	840	840	100.0	sul1.l6.c4.ctg.1	946	5.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sul1;Sul1 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria. It is linked to other resistance genes of class 1 integrons.
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	734	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1860	21.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
